Atlas Trials

Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon

Clinical trial NCT02486640 · COMPLETED

Trial details

NCT number
NCT02486640
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2015-09-08
Primary completion
2019-10-31
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.